|
|
Volumn 357, Issue 9258, 2001, Pages 801-802
|
|
Liposomal amphotericin B [3]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMPHOTERICIN B LIPID COMPLEX;
LIPID;
AMPHOTERICIN B;
ANTIPROTOZOAL AGENT;
LIPOSOME;
ANTIBIOTIC RESISTANCE;
BACTERIUM;
CLINICAL FEATURE;
DISEASE COURSE;
DRUG COST;
DRUG EFFECT;
LEISHMANIA DONOVANI;
LETTER;
LONG TERM CARE;
NEPHROTOXICITY;
NONHUMAN;
PRIORITY JOURNAL;
RISK FACTOR;
TREATMENT OUTCOME;
ANIMAL;
HUMAN;
NOTE;
VISCERAL LEISHMANIASIS;
AMPHOTERICIN B;
ANIMALS;
ANTIPROTOZOAL AGENTS;
HUMANS;
LEISHMANIA DONOVANI;
LEISHMANIASIS, VISCERAL;
LIPOSOMES;
|
|
EID: 0035835776
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(05)71224-1 Document Type: Letter |
|
Times cited : (10)
|
|
References (4)
|
